Table 3

Cohen’s Kappa showing rater-rater reliability for confidence questions
Question stem–How confident are you at: Cohen’s Kappa SE Probability p 95% CI Count n
…managing hypertension as a disease? 0.458 0.113 p < 0.001 0.237 to 0.679 53
…managing hypertension in patients with CKD? 0.628 0.090 p < 0.001 0.452 to 0.804 53
…managing hypertension in patients with CKD with Diabetes? 0.562 0.095 p < 0.001 0.376 to 0.748 53
..that you can achieve lowered blood pressure in patients with CKD? 0.569 0.103 p < 0.001 0.367 to 0.771 53
…interpreting eGFR to stage CKD? 0.561 0.087 p < 0.001 0.39 to 0.732 53
..with monitoring eGFR in patients with CKD? 0.426 0.092 p < 0.001 0.246 to 0.606 53
…monitoring eGFR in CKD patient with Diabetes? 0.413 0.091 p < 0.001 0.235 to 0.591 53
…identifying significant proteinuria in patients with Diabetes? 0.495 0.097 p < 0.001 0.305 to 0.685 53
…identifying significant proteinuria in patients with CKD? 0.481 0.094 p < 0.001 0.297 to 0.665 52
…using urine protein (ACR or PCR) results to manage Diabetes? 0.421 0.093 p < 0.001 0.239 to 0.603 52
…using urine protein (ACR or PCR) results to manage CKD? 0.486 0.094 p < 0.001 0.302 to 0.67 51
…using ACE inhibitors and / or ARB’s? 0.589 0.094 p < 0.001 0.405 to 0.773 53
…using ACE inhibitors and / or ARB’s in patients with CKD? 0.591 0.089 p < 0.001 0.417 to 0.765 53
..using other anti-hypertensives in patients with CKD? 0.508 0.096 p < 0.001 0.32 to 0.696 53
…in adding a loop diuretic drug to patients with CKD (stage 3b and above) already on maximum dose of an ACE inhibitor and/or ARB? 0.608 0.0896 p < 0.001 0.432 to 0.784 53
…identifying CVD risk factors for patients with CKD? 0.573 0.100 p < 0.001 0.377 to 0.769 53
…assessing CVD risk scores in patients with Diabetes? 0.539 0.097 p < 0.001 0.349 to 0.729 53
…assessing CVD risk scores in patients with CKD? 0.523 0.099 p < 0.001 0.329 to 0.717 53
…initiating therapy to lower lipid levels in patients with heart disease? 0.557 0.106 p < 0.001 0.349 to 0.765 53
…initiating therapy to lower lipid levels in patients with CKD? 0.603 0.091 p < 0.001 0.425 to 0.781 53
…using referral guidelines to refer appropriate patients with Diabetes (Type 2) to secondary care? 0.489 0.095 p < 0.001 0.303 to 0.675 53
…using referral guidelines to refer appropriate patients with CKD to secondary care? 0.558 0.086 p < 0.001 0.389 to 0.727 53
…the overall management of patients with Diabetes (Type 2)? 0.545 0.098 p < 0.001 0.353 to 0.737 53
…the overall management of patients with CKD? 0.543 0.091 p < 0.001 0.365 to 0.721 53

Tahir et al.

Tahir et al. BMC Nephrology 2014 15:73   doi:10.1186/1471-2369-15-73

Open Data